# Vishay Intertechnology Inc: financial statements, quarterly

VSH · NYSE · CIK 103730 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vsh.md) · [Financials](/companies/vsh/financials.md) · [Filings](/companies/vsh/filings.md) · [Insiders](/companies/vsh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vsh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [854](/filings/0000103730-24-000122.md) | [785 d](/filings/0000103730-26-000019.md) | [746](/filings/0000103730-25-000037.md) | [741](/filings/0000103730-25-000055.md) | [735](/filings/0000103730-25-000067.md) | [715 d](/filings/0000103730-26-000019.md) | [715](/filings/0000103730-26-000038.md) | [762](/filings/0000103730-26-000065.md) | [791](/filings/0000103730-25-000067.md) | [801 d](/filings/0000103730-26-000019.md) | [839](/filings/0000103730-26-000038.md) | [889](/filings/0000103730-26-000065.md) |
| Cost of revenue | $m | not reported | not reported | [576](/filings/0000103730-25-000037.md) | [578](/filings/0000103730-25-000055.md) | [584](/filings/0000103730-25-000067.md) | [573 d](/filings/0000103730-26-000019.md) | [580](/filings/0000103730-26-000038.md) | [614](/filings/0000103730-26-000065.md) | [637](/filings/0000103730-25-000067.md) | [644 d](/filings/0000103730-26-000019.md) | [663](/filings/0000103730-26-000038.md) | [681](/filings/0000103730-26-000065.md) |
| Gross profit | $m | [238](/filings/0000103730-24-000122.md) | [201 d](/filings/0000103730-26-000019.md) | [170](/filings/0000103730-25-000037.md) | [163](/filings/0000103730-25-000055.md) | [151](/filings/0000103730-25-000067.md) | [142 d](/filings/0000103730-26-000019.md) | [136](/filings/0000103730-26-000038.md) | [149](/filings/0000103730-26-000065.md) | [154](/filings/0000103730-25-000067.md) | [157 d](/filings/0000103730-26-000019.md) | [177](/filings/0000103730-26-000038.md) | [207](/filings/0000103730-26-000065.md) |
| Selling, general and administrative | $m | [123](/filings/0000103730-24-000122.md) | [123 d](/filings/0000103730-26-000019.md) | [128](/filings/0000103730-25-000037.md) | [125](/filings/0000103730-25-000055.md) | [129](/filings/0000103730-25-000067.md) | [132 d](/filings/0000103730-26-000019.md) | [135](/filings/0000103730-26-000038.md) | [127](/filings/0000103730-26-000065.md) | [135](/filings/0000103730-25-000067.md) | [142 d](/filings/0000103730-26-000019.md) | [154](/filings/0000103730-26-000038.md) | [154](/filings/0000103730-26-000065.md) |
| Operating income | $m | [115](/filings/0000103730-24-000122.md) | [77.8 d](/filings/0000103730-26-000019.md) | [42.7](/filings/0000103730-25-000037.md) | [37.9](/filings/0000103730-25-000055.md) | [(18.3)](/filings/0000103730-25-000067.md) | [(56.7) d](/filings/0000103730-26-000019.md) | [0.8](/filings/0000103730-26-000038.md) | [22.1](/filings/0000103730-26-000065.md) | [19.1](/filings/0000103730-25-000067.md) | [14.8 d](/filings/0000103730-26-000019.md) | [22.1](/filings/0000103730-26-000038.md) | [53.5](/filings/0000103730-26-000065.md) |
| Interest expense | $m | [7.2](/filings/0000103730-23-000086.md) | [6.5 d](/filings/0000103730-24-000034.md) | [6.5](/filings/0000103730-24-000084.md) | [6.7](/filings/0000103730-24-000102.md) | [6.6](/filings/0000103730-25-000067.md) | [7.7 d](/filings/0000103730-26-000019.md) | [8.8](/filings/0000103730-26-000038.md) | [10.6](/filings/0000103730-26-000065.md) | [9.5](/filings/0000103730-25-000067.md) | [9.7 d](/filings/0000103730-26-000019.md) | [10.0](/filings/0000103730-26-000038.md) | [10.3](/filings/0000103730-26-000065.md) |
| Income tax | $m | [30.6](/filings/0000103730-24-000122.md) | [28.7 d](/filings/0000103730-26-000019.md) | [12.8](/filings/0000103730-25-000037.md) | [12.4](/filings/0000103730-25-000055.md) | [(5.1)](/filings/0000103730-25-000067.md) | [7.2 d](/filings/0000103730-26-000019.md) | [(0.1)](/filings/0000103730-26-000038.md) | [10.3](/filings/0000103730-26-000065.md) | [19.8](/filings/0000103730-25-000067.md) | [4.6 d](/filings/0000103730-26-000019.md) | [5.7](/filings/0000103730-26-000038.md) | [14.3](/filings/0000103730-26-000065.md) |
| Net income | $m | [65.5](/filings/0000103730-24-000122.md) | [51.5 d](/filings/0000103730-26-000019.md) | [30.9](/filings/0000103730-25-000037.md) | [23.5](/filings/0000103730-25-000055.md) | [(19.3)](/filings/0000103730-25-000067.md) | [(66.3) d](/filings/0000103730-26-000019.md) | [(4.1)](/filings/0000103730-26-000065.md) | [2.0](/filings/0000103730-26-000065.md) | [(7.9)](/filings/0000103730-25-000067.md) | [1.0 d](/filings/0000103730-26-000019.md) | [7.2](/filings/0000103730-26-000065.md) | [28.1](/filings/0000103730-26-000065.md) |
| Diluted EPS | $ per share | [0.47](/filings/0000103730-24-000122.md) | not reported | [0.22](/filings/0000103730-25-000037.md) | [0.17](/filings/0000103730-25-000055.md) | [(0.14)](/filings/0000103730-25-000067.md) | not reported | [(0.03)](/filings/0000103730-26-000038.md) | [0.01](/filings/0000103730-26-000065.md) | [(0.06)](/filings/0000103730-25-000067.md) | not reported | [0.05](/filings/0000103730-26-000038.md) | [0.19](/filings/0000103730-26-000065.md) |
| Basic EPS | $ per share | [0.47](/filings/0000103730-24-000122.md) | not reported | [0.22](/filings/0000103730-25-000037.md) | [0.17](/filings/0000103730-25-000055.md) | [(0.14)](/filings/0000103730-25-000067.md) | not reported | [(0.03)](/filings/0000103730-26-000038.md) | [0.01](/filings/0000103730-26-000065.md) | [(0.06)](/filings/0000103730-25-000067.md) | not reported | [0.05](/filings/0000103730-26-000038.md) | [0.21](/filings/0000103730-26-000065.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,095](/filings/0000103730-23-000086.md) | [973](/filings/0000103730-25-000017.md) | [797](/filings/0000103730-24-000084.md) | [673](/filings/0000103730-24-000102.md) | [644](/filings/0000103730-24-000122.md) | [590](/filings/0000103730-26-000019.md) | [609](/filings/0000103730-25-000037.md) | [474](/filings/0000103730-25-000055.md) | [444](/filings/0000103730-25-000067.md) | [515](/filings/0000103730-26-000065.md) | [479](/filings/0000103730-26-000038.md) | [1,297](/filings/0000103730-26-000065.md) |
| Current assets | $m | [2,440](/filings/0000103730-23-000086.md) | [2,297](/filings/0000103730-25-000017.md) | [2,143](/filings/0000103730-24-000084.md) | [1,997](/filings/0000103730-24-000102.md) | [2,011](/filings/0000103730-24-000122.md) | [1,916](/filings/0000103730-26-000019.md) | [1,976](/filings/0000103730-25-000037.md) | [1,912](/filings/0000103730-25-000055.md) | [1,895](/filings/0000103730-25-000067.md) | [1,887](/filings/0000103730-26-000065.md) | [1,877](/filings/0000103730-26-000038.md) | [2,725](/filings/0000103730-26-000065.md) |
| Total assets | $m | [4,241](/filings/0000103730-23-000086.md) | [4,240](/filings/0000103730-26-000019.md) | [4,264](/filings/0000103730-25-000037.md) | [4,153](/filings/0000103730-25-000055.md) | [4,220](/filings/0000103730-25-000067.md) | [4,111](/filings/0000103730-26-000019.md) | [4,200](/filings/0000103730-26-000038.md) | [4,222](/filings/0000103730-26-000065.md) | [4,196](/filings/0000103730-25-000067.md) | [4,234](/filings/0000103730-26-000065.md) | [4,263](/filings/0000103730-26-000038.md) | [5,156](/filings/0000103730-26-000065.md) |
| Current liabilities | $m | [717](/filings/0000103730-23-000086.md) | [692](/filings/0000103730-25-000017.md) | [709](/filings/0000103730-24-000084.md) | [670](/filings/0000103730-24-000102.md) | [714](/filings/0000103730-24-000122.md) | [708](/filings/0000103730-26-000019.md) | [705](/filings/0000103730-25-000037.md) | [707](/filings/0000103730-25-000055.md) | [711](/filings/0000103730-25-000067.md) | [720](/filings/0000103730-26-000065.md) | [712](/filings/0000103730-26-000038.md) | [1,512](/filings/0000103730-26-000065.md) |
| Total liabilities | $m | [2,099](/filings/0000103730-23-000086.md) | [2,039](/filings/0000103730-25-000017.md) | [2,077](/filings/0000103730-24-000084.md) | [1,971](/filings/0000103730-24-000102.md) | [2,047](/filings/0000103730-24-000122.md) | [2,082](/filings/0000103730-26-000019.md) | [2,168](/filings/0000103730-25-000037.md) | [2,127](/filings/0000103730-25-000055.md) | [2,113](/filings/0000103730-25-000067.md) | [2,146](/filings/0000103730-26-000065.md) | [2,187](/filings/0000103730-26-000038.md) | [2,243](/filings/0000103730-26-000065.md) |
| Long-term debt | $m | [817](/filings/0000103730-23-000086.md) | [818](/filings/0000103730-25-000017.md) | [819](/filings/0000103730-24-000084.md) | [821](/filings/0000103730-24-000102.md) | [821](/filings/0000103730-24-000122.md) | [905](/filings/0000103730-26-000019.md) | [988](/filings/0000103730-25-000037.md) | [915](/filings/0000103730-25-000055.md) | [920](/filings/0000103730-25-000067.md) | [951](/filings/0000103730-26-000065.md) | [983](/filings/0000103730-26-000038.md) | [235](/filings/0000103730-26-000065.md) |
| Current portion of debt | $m | [0.0](/filings/0000103730-23-000086.md) | [0.0](/filings/0000103730-25-000017.md) | [0.0](/filings/0000103730-24-000084.md) | [0.0](/filings/0000103730-24-000102.md) | [0.0](/filings/0000103730-24-000122.md) | [0.0](/filings/0000103730-26-000019.md) | [0.0](/filings/0000103730-25-000037.md) | [0.0](/filings/0000103730-25-000055.md) | [0.0](/filings/0000103730-25-000067.md) | [0.0](/filings/0000103730-26-000065.md) | [0.0](/filings/0000103730-26-000038.md) | [738](/filings/0000103730-26-000065.md) |
| Shareholders' equity | $m | [2,138](/filings/0000103730-23-000086.md) | [2,196](/filings/0000103730-25-000017.md) | [2,182](/filings/0000103730-24-000084.md) | [2,176](/filings/0000103730-24-000102.md) | [2,168](/filings/0000103730-24-000122.md) | [2,029](/filings/0000103730-26-000019.md) | [2,032](/filings/0000103730-25-000037.md) | [2,095](/filings/0000103730-25-000055.md) | [2,083](/filings/0000103730-25-000067.md) | [2,088](/filings/0000103730-26-000065.md) | [2,076](/filings/0000103730-26-000038.md) | [2,913](/filings/0000103730-26-000065.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0000103730-24-000122.md) | [6.3 d](/filings/0000103730-26-000019.md) | [80.2](/filings/0000103730-25-000037.md) | [(24.7) d](/filings/0000103730-25-000055.md) | [50.6 d](/filings/0000103730-25-000067.md) | [67.7 d](/filings/0000103730-26-000019.md) | [16.1](/filings/0000103730-26-000038.md) | [(8.8) d](/filings/0000103730-26-000065.md) | [27.6 d](/filings/0000103730-25-000067.md) | [149 d](/filings/0000103730-26-000019.md) | [63.7](/filings/0000103730-26-000038.md) | [105 d](/filings/0000103730-26-000065.md) |
| Capital expenditure | $m | [66.8 d](/filings/0000103730-24-000122.md) | [145 d](/filings/0000103730-26-000019.md) | [53.1](/filings/0000103730-25-000037.md) | [62.6 d](/filings/0000103730-25-000055.md) | [59.5 d](/filings/0000103730-25-000067.md) | [145 d](/filings/0000103730-26-000019.md) | [61.6](/filings/0000103730-26-000038.md) | [64.6 d](/filings/0000103730-26-000065.md) | [52.3 d](/filings/0000103730-25-000067.md) | [94.8 d](/filings/0000103730-26-000019.md) | [111](/filings/0000103730-26-000038.md) | [95.2 d](/filings/0000103730-26-000065.md) |
| Share repurchases | $m | [17.3 d](/filings/0000103730-24-000122.md) | [21.0 d](/filings/0000103730-26-000019.md) | [12.5](/filings/0000103730-25-000037.md) | [12.6 d](/filings/0000103730-25-000055.md) | [12.6 d](/filings/0000103730-25-000067.md) | [12.6 d](/filings/0000103730-26-000019.md) | [12.5](/filings/0000103730-26-000038.md) | [0.0 d](/filings/0000103730-26-000065.md) | [0.0 d](/filings/0000103730-25-000067.md) | [(0.0) d](/filings/0000103730-26-000019.md) | [0.0](/filings/0000103730-26-000038.md) | [0.0 d](/filings/0000103730-26-000065.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [143](/filings/0000103730-23-000086.md) | [141](/filings/0000103730-24-000084.md) | [140](/filings/0000103730-24-000102.md) | [140](/filings/0000103730-24-000122.md) | [138](/filings/0000103730-25-000037.md) | [138](/filings/0000103730-25-000055.md) | [137](/filings/0000103730-25-000067.md) | [136](/filings/0000103730-26-000038.md) | [136](/filings/0000103730-26-000065.md) | [136](/filings/0000103730-25-000067.md) | [137](/filings/0000103730-26-000038.md) | [148](/filings/0000103730-26-000065.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 131,143,534 at 2012-07-27, from the cover of the [10-Q filed 2012-07-31](/filings/0000103730-12-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.